Description

Cinnarizin (Cinnarizinum) tablets 25 mg. №50

Ingredients

Each tablet contains 25 mg of Cinnarizine.

Dosage

The usual dose is 25 mg (1 tablet) two to three times daily.

Indications

Cinnarizin tablets are indicated for the treatment of vertigo, Meniere’s disease, and motion sickness.

Contraindications

Do not use Cinnarizin tablets in patients with Parkinson’s disease, severe hypotension, or hypersensitivity to cinnarizine.

Directions

Take Cinnarizin tablets orally with or after meals to reduce gastrointestinal irritation.

Scientific Evidence

Cinnarizine is a calcium channel blocker with antihistaminic properties that is effective in the treatment of vertigo and motion sickness. Studies have shown that cinnarizine can significantly reduce the severity and frequency of vertigo attacks in patients with Meniere’s disease.

Research published in the International Tinnitus Journal demonstrated the efficacy of cinnarizine in improving symptoms of vertigo and tinnitus associated with Meniere’s disease. The study concluded that cinnarizine is a safe and effective treatment option for patients with these conditions.

Additional Information

Cinnarizin tablets may cause drowsiness, so it is advisable to avoid driving or operating heavy machinery until you know how the medication affects you. It is important to follow the prescribed dosage and not exceed the recommended amount to avoid adverse effects.

Consult your healthcare provider before taking Cinnarizin tablets if you are pregnant, breastfeeding, or have any underlying medical conditions. Inform your doctor about any other medications or supplements you are taking to prevent potential drug interactions.